Cytosorbents
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-6-7.2-7.20.6
Price/Sales ratio
1.000.890.860.21
Earnings per Share (EPS)
$-0.18$-0.15$-0.15$1.8

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-15.35-17.04-11.61-21.21-14.42-6.44-39.47-7.39-2.05-1.73-3.93-14.42
Price/Sales ratio
45.5034.1716.8913.4112.255.457.844.522.301.364.405.45
Price/Book Value ratio
36.1116.88-292.3717.4814.6536.333.902.901.902.123.6536.33
Price/Cash Flow ratio
-21.48-15.38-20.59-27.78-22.89-7.41-55.11-12.97-2.39-2.28-4.57-22.89
Price/Free Cash Flow ratio
-20.36-14.36-18.91-22.05-20.08-6.79-42.44-9.93-1.94-2.19-3.72-20.08
Price/Earnings Growth ratio
-0.510.34-0.270.62-0.17-0.900.59-0.03-0.060.110.14-0.17
Dividend Yield
N/AN/AN/A0.18%N/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
32.14%45.44%51.81%58.76%63.01%67.65%71.98%72.45%52.46%61.60%52.46%67.65%
Operating Profit Margin
-231.44%-229.39%-140.04%-73.55%-76.95%-83.34%-26.28%-56.70%-107.36%-85.85%-107.36%-83.34%
Pretax Profit Margin
-308.64%-208.50%-149.37%-68.28%-88.04%-89.42%-22.72%-63.06%-115.48%-80.66%-115.48%-89.42%
Net Profit Margin
-296.37%-200.49%-145.48%-63.22%-84.98%-84.62%-19.86%-61.23%-111.76%-78.42%-111.75%-84.62%
Effective Tax Rate
3.97%3.83%2.59%7.40%3.47%5.36%12.57%2.90%3.22%2.77%3.22%5.36%
Return on Assets
-110.06%-72.25%-123.15%-35.10%-52.55%-70.35%-8.71%-27.43%-51.89%-53.52%-51.89%-52.55%
Return On Equity
-235.20%-99.03%2518.28%-82.44%-101.63%-563.66%-9.89%-39.24%-92.75%-122.47%-73.94%-101.63%
Return on Capital Employed
-183.67%-113.31%-318.85%-60.55%-59.46%-108.75%-12.99%-29.99%-58.90%-80.61%-58.90%-59.46%
Liquidity Ratios
Current Ratio
1.683.231.282.644.322.108.12N/AN/AN/A3.472.10
Quick Ratio
1.562.841.142.544.191.897.854.343.111.512.861.89
Cash ratio
0.801.740.862.203.421.237.033.802.270.972.271.23
Days of Sales Outstanding
95.0658.3963.7560.1671.0671.6147.7341.1670.4260.8270.4271.61
Days of Inventory outstanding
92.01196.4276.9952.6240.60104.7888.30157.4590.5196.2390.5340.60
Operating Cycle
187.08254.82140.75112.79111.66176.40136.03198.62160.94157.06107.89176.40
Days of Payables Outstanding
119.43112.94122.7882.3072.41101.0760.5992.6743.2899.4365.53101.07
Cash Conversion Cycle
67.64141.8717.9630.4839.2575.3275.43105.94117.6557.6327.2175.32
Debt Ratios
Debt Ratio
N/AN/A0.500.410.300.54N/AN/A0.070.090.440.30
Debt Equity Ratio
N/AN/A-10.360.970.584.40N/AN/A0.140.210.780.58
Long-term Debt to Capitalization
N/AN/A1.130.360.350.79N/AN/A0.120.090.330.79
Total Debt to Capitalization
N/AN/A1.100.490.360.81N/AN/A0.120.170.340.81
Interest Coverage Ratio
-23.47-1.00KN/AN/A-10.66-18.35-8.63N/AN/AN/A-237.73-18.35
Cash Flow to Debt Ratio
N/AN/A-1.37-0.64-1.09-1.11N/AN/A-5.64-4.29-1.54-1.11
Company Equity Multiplier
2.131.37-20.442.341.938.011.131.431.782.281.788.01
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-2.11-2.22-0.82-0.48-0.53-0.73-0.14-0.34-0.96-0.59-0.96-0.73
Free Cash Flow / Operating Cash Flow Ratio
1.051.071.081.251.141.091.291.301.221.041.221.14
Cash Flow Coverage Ratio
N/AN/A-1.37-0.64-1.09-1.11N/AN/A-5.64-4.29-1.54-1.11
Short Term Coverage Ratio
N/AN/A-8.07-1.61-16.25-10.05N/AN/AN/A-8.66-259.17-10.05
Dividend Payout Ratio
N/AN/AN/A-3.96%N/AN/AN/AN/AN/AN/AN/AN/A